A. Soubrier

Treatment response, drug survival and safety of anti-tumour necrosis factor α therapy in 193 patients with psoriatic arthritis: a twelve-year "real life" experience.

B. Cortet, R. Flipo, J. Paccou, 2015, Joint, bone, spine : revue du rhumatisme.

Fibroblast growth factor 2 inhibits up-regulation of bone morphogenic proteins and their receptors during osteoblastic differentiation of human mesenchymal stem cells.

B. Cortet, P. Hardouin, O. Broux, 2012, Biochemical and biophysical research communications.